QIAGEN N.V. (QGEN)

NL0012169213 - Common Stock

39.345  -0.27 (-0.67%)

QIAGEN N.V.

NYSE:QGEN (9/27/2023, 11:32:26 AM)

39.345

-0.27 (-0.67%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-08 2023-08-08/amc
Earnings (Next)11-06 2023-11-06/amc
Ins OwnersN/A
Inst Owners62.74%
Market Cap8.97B
Shares228.03M
PE18.92
Fwd PE17.52
Dividend YieldN/A
Analysts73.04
IPO09-01 1996-09-01
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

QGEN Daily chart

Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 6,100 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Company Info

QIAGEN N.V.

Hulsterweg 82

Venlo LIMBURG 5912

P: 31773556600.0

CEO: Thierry Bernard

Employees: 6100

Website: https://www.qiagen.com/

QGEN News

News Image2 days ago - QIAGEN N.V.QIAGEN enhances QIAwave portfolio with new eco-friendlier nucleic acid extraction kits

New kits reduce use of plastics by up to 62% and cardboard by up to 58% compared to QIAGEN standard kits // Two additions to growing QIAwave portfolio:...

News Image2 days ago - QIAGEN N.V.QIAGEN erweitert QIAwave-Portfolio um neue, umweltfreundlichere Nukleinsäure-Extraktionskits

Im Vergleich zu Standardkits von QIAGEN bis zu 62% weniger Kunststoff und bis zu 58% weniger Pappe eingesetzt // Zwei Neuzugänge im wachsenden...

News Image19 days ago - Market News VideoRSI Alert: Qiagen (QGEN) Now Oversold
News Imagea month ago - Market News VideoQGEN August 2024 Options Begin Trading
News Image2 months ago - Seeking AlphaQiagen Non-GAAP EPS of $0.51 beats by $0.01, revenue of $497M beats by $4.02M (NYSE:QGEN)

Qiagen press release (QGEN): Q2 Non-GAAP EPS of $0.51 beats by $0.01.Revenue of $497M beats by $4.02M.QIAGEN has revised its full-year 2023 outlook for net sales of at least...

News Image2 months ago - QIAGEN N.V.QIAGEN übertrifft Prognose für zweites Quartal 2023 mit Umsatzwachstum von 9% (CER) bei Nicht-COVID-Produkten und passt Jahresprognose an

Q2 2023: Konzernumsatz von $495 Mio. (-4% bei tatsächlichen Kursen; -4% bei konstanten Wechselkursen, CER); verwässerter Gewinn je Aktie von $0,35;...

QGEN Twits

Here you can normally see the latest stock twits on QGEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example